Skip to content

Saint Luc Valve Registry

Saint Luc Valve Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02974218
Acronym
SaLVaRe
Enrollment
5000
Registered
2016-11-28
Start date
2000-01-31
Completion date
2025-01-31
Last updated
2019-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)

Brief summary

The Cliniques Universitaires Saint Luc are one of the high specialized center in valvular heart diseases and valvular heart surgery. Aortic stenosis, mitral and aortic regurgitation are the three valve pathology that are mainly frequent and studied. International guidelines in the management of valvular heart diseases are based on few limited old studies, mainly retrospective. And, a matter of concern is staying, about the timing of surgery for asymptomatic patients. A prospective registry will help us to better understand the pathologies and try to better define guidelines criteria for surgery.

Detailed description

With this prospective registry, all patients with aortic stenosis, mitral and aortic regurgitation will be followed. The investigators will find followed patients not yet operated or until surgery, but also patient after surgery according to the presence or abscence of guidelines criteria. It will permit to compare different kind of management of patients with valvular heart disease and to better define guidelines criteria for surgery.

Interventions

None listed

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Presence of aortic stenosis, mitral or aortic regurgitation at the time of an echocardiography at the Cliniques Universitaires Saint Luc.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Overall survivalevery two years up to 10 yearsFrom the date of the first echocardiography until the date of death from any cause, documented progression and surgery will be regularly assessed up to 10 years.

Countries

Belgium

Contacts

Primary Contactde Meester Christophe, PhD
christophe.demeester@uclouvain.be003227642816

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026